Toxicological assessment of nanoparticle interactions with the pulmonary system
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Nanoparticle(NP)-based materials have breakthrough applications in many fields of life, such as in engineering, communications and textiles industries; food and bioenvironmental applications; medicines and cosmetics, etc. Biomedical applications of NPs are very active areas of research with successful translation to pharmaceutical and clinical uses overcoming both pharmaceutical and clinical challenges. Although the attractiveness and enhanced applications of these NPs stem from their exceptional properties at the nanoscale size, i.e. 1–1000 nm, they exhibit completely different physicochemical profiles and, subsequently, toxicological profiles from their parent bulk materials. Hence, the clinical evaluation and toxicological assessment of NPs interactions within biological systems are continuously evolving to ensure their safety at the nanoscale. The pulmonary system is one of the primary routes of exposure to airborne NPs either intentionally, via aerosolized nanomedicines targeting pulmonary pathologies such as cancer or asthma, or unintentionally, via natural NPs and anthropogenic (man-made) NPs. This review presents the state-of-the-art, contemporary challenges, and knowledge gaps in the toxicological assessment of NPs interactions with the pulmonary system. It highlights the main mechanisms of NP toxicity, factors influencing their toxicity, the different toxicological assessment methods and their drawbacks, and the recent NP regulatory guidelines based on literature collected from the research pool of NPs interactions with lung cell lines, in vivo inhalation studies, and clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149 · cited 1×
“The renal clearance is limited to NP or NP products size lower than 8 nm (Longmire, Choyke, and Kobayashi 2008).”
BackgroundMonopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Limbach, L. K., Li, Y., Grass, R. N., Brunner, T. J., Hintermann, M. A., Muller, M., Gunther, D., & Stark, W. J. (2005) · Environmental Science & Technology · doi:10.1021/es051043o · Cited by 779 · cited 1×
“…of NPs could play a double effect; it could increase the NPs uptake as larger amounts and more particles will sediment on the cellular surface (Limbach et al. 2005), or it could reduce the cellular uptake if the aggregates are bigger than cellular size to permit the uptake (Drescher et al.…”
BackgroundThe role of micelle size in tumor accumulation, penetration, and treatment
Wang, J., Mao, W., Lock, L. L., Tang, J., Sui, M., Sun, W., Cui, H., Xu, D., & Shen, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b02017 · Cited by 635
Heyder, J. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-046ta · Cited by 601 · cited 1×
“…air (Nebulizers, DPI), or a propellant, and lastly but equally important, patient factors; the underlying pulmonary pathophysiology including the respiratory volumes, breath-holding, and the severity of the lung disease (Heyder 2004, Stein and Thiel 2017, Rangaraj, Pailla, and Sampathi 2019).”
BackgroundThe importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
The Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
Hughes, P., Marshall, D., Reid, Y., Parkes, H., & Gelber, C. (2007) · BioTechniques · doi:10.2144/000112598 · Cited by 434 · cited 1×
“3 D models have closer representation of a mixture of different cell types within the tissue and provide the cell-cell interaction and communication with enhanced in vivo correlated results (Hughes et al. 2007, Jones and Grainger 2009).”
BackgroundIn silico toxicology protocols
Myatt, G. J., Ahlberg, E., Akahori, Y., Allen, D., Amberg, A., Anger, L. T., Aptula, A., Auerbach, S., Beilke, L., Bellion, P., et al. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.04.014 · Cited by 240 · cited 2×
“…and validated to increase the sensitivity and the in vivo translation of the in vitro models, such as ex vivo models, dynamic organoids or miniaturized body-on-chip systems, and in silico models (Myatt et al. 2018; Oberdorster and Kuhlbusch 2018; Rothen-Rutishauser, Bourquin, and Petri-Fink 2019).”
Background
Cited by
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Advances in nanomaterial-based targeted drug delivery systems
Cheng, X., Xie, Q., & Sun, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1177151 · Cited by 395
Magnetic Iron Nanoparticles: Synthesis, Surface Enhancements, and Biological Challenges
Vargas-Ortiz, J. R., Gonzalez, C., & Esquivel, K. (2022) · Processes · doi:10.3390/pr10112282 · Cited by 62
Nanoparticles toxicity: An overview of its mechanism and plausible mitigation strategies
Sharma, N., Kurmi, B. D., Singh, D., Mehan, S., Khanna, K., Karwasra, R., Kumar, S., Chaudhary, A., Jakhmola, V., Sharma, A., et al. (2024) · Journal of Drug Targeting · doi:10.1080/1061186x.2024.2316785 · Cited by 58
“The study concludes that the cytoskeleton damage of human lung epithelial cells could have an impact on the integrity of alveoli function [21, 22].”
Background
Metadata
- Authors
- Osman, N. M., Sexton, D. W., & Saleem, I. Y.
- Venue
- Nanotoxicology
- Publisher
- Informa UK Limited
- Published
- 2019-09-10
- Volume
- 14
- Issue
- 1
- Pages
- 21-58
- ISSN
- 1743-5390 (ISSN-L)
- 1743-5404
- OpenAlex
- W2972534123
- Cited by
- 61
- References
- 11
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toxicological assessment of nanoparticle interactions with the pulmonary system. https://app.cochat.ai/papers/10.1080/17435390.2019.1661043
- The paper
- Osman, N. M., Sexton, D. W., & Saleem, I. Y. (2020). Toxicological assessment of nanoparticle interactions with the pulmonary system. Nanotoxicology. https://doi.org/10.1080/17435390.2019.1661043
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.